Overview
As a T2T, our patients with idiopathic inflammatory myopathies will receive pulse therapies with methyprednisolone and/or human intravenous immunoglobulin, or only methyprednisolone at disease onset.
This scheme is an internal routine protocol of our Service.
Description
To compare two groups of patients as described in Brief Summary.
Eligibility
Inclusion Criteria:
- Idiopathic inflammatory myopathies
Exclusion Criteria:
- Inclusion body myositis, muscular dystrophies, neoplasia-associated myopathies, overlapped myopathies, others myopathies